Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa
As antiretroviral therapy (ART) programs in sub-Saharan Africa mature, increasing numbers of persons with human immunodeficiency virus (HIV) infection will experience treatment failure, and require second- or third-line ART. Data on second-line failure and development of protease inhibitor (PI) resistance in sub-Saharan Africa are scarce.
HIV-1–infected adults were included if they received >180 days of PI-based second-line ART. We assessed risk fa...
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher copy:
- Copyright holder:
- Boender et al
- Copyright date:
- © The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved.
If you are the owner of this record, you can report an update to it here: Report update to this record